Literature DB >> 28748512

Cross-cultural adaptation and validation of the Chinese version of the Health Assessment Questionnaire for the Spondyloarthropathies (HAQ-S).

DeLin Liu1, Chen Zhang1, Chen Wang1, Jiao Liu2, DaHe Li3, Jia Li4, Weidong Xu5.   

Abstract

The Health Assessment Questionnaire for Spondyloarthropathies (HAQ-S) is a commonly used questionnaire to evaluate function and health status of patients with ankylosing spondylitis (AS). The objective of this study was to cross-culturally adapt the HAQ-S into Chinese and then to evaluate its reliability and validity. The Chinese version of the HAQ-S was obtained with a five-step procedure of translation and cross-cultural adaptation. All invited patients met the New York criteria for AS, and a total of 103 patients finally participated in this study. Intraclass correlation coefficient (ICC) was used to evaluate the test-retest and inter-rater reliability of the HAQ-S. Internal consistency of the questionnaire was evaluated by Cronbach's alpha coefficient. Spearman's correlation coefficient was calculated to assess the construct validity between the HAQ-S and Bath AS Disease Activity Index (BASDAI), Bath AS Functional Index (BASFI), Bath AS Metrology Index (BASMI), and the laboratory parameters (erythrocyte sedimentation rate, ESR; C-reactive protein, CRP). Test-retest and inter-rater reliability were excellent with intraclass correlation coefficients of 0.987 (p < 0.05) and 0.982 (p < 0.05), respectively. The overall internal consistency of the HAQ-S was found satisfactory (Cronbach's alpha = 0.914). The Chinese version of the HAQ-S correlated good with the BASFI (r = 0.749, p < 0.01), and moderate with the BASDAI (r = 0.581, p < 0.01) and the BASMI (r = 0.425, p < 0.01). But, the adapted questionnaire correlated poorly with ESR (r = 0.298, p < 0.01) or CRP (r = 0.283, p < 0.01). The Chinese version of the HAQ-S is reliable and valid for the evaluation of Chinese-speaking patients with AS.

Entities:  

Keywords:  Ankylosing spondylitis; Chinese; HAQ-S; Translation; Validation

Mesh:

Year:  2017        PMID: 28748512     DOI: 10.1007/s10067-017-3759-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  28 in total

1.  The Health Assessment Questionnaire (HAQ).

Authors:  B Bruce; J F Fries
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

Review 2.  Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Authors:  F Guillemin; C Bombardier; D Beaton
Journal:  J Clin Epidemiol       Date:  1993-12       Impact factor: 6.437

3.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

4.  Validity and reliability of the Health Assessment Questionnaire among patients with spondyloarthritis in Singapore.

Authors:  Yu Heng Kwan; Warren Fong; Nai Lee Lui; Si Ting Yong; Yin Bun Cheung; Rahul Malhotra; Julian Thumboo; Truls Østbye
Journal:  Int J Rheum Dis       Date:  2016-11-14       Impact factor: 2.454

5.  Validity and reliability of the Turkish version of the Health Assessment Questionnaire for the Spondyloarthropathies.

Authors:  Esra Ozcan; Ozlem Yilmaz; Ahmet Tutoglu; Hatice Bodur
Journal:  Rheumatol Int       Date:  2011-02-16       Impact factor: 2.631

6.  Transcultural adaptation and validation of the Chinese version of the intermittent and constant osteoarthritis pain (ICOAP) measure in patients with knee osteoarthritis.

Authors:  C Zhang; D H Liu; Y L Qu; Z Y Jia; W Wang; J Li; W D Xu
Journal:  Osteoarthritis Cartilage       Date:  2016-12-01       Impact factor: 6.576

7.  Factors related to change in global health after group physical therapy in ankylosing spondylitis.

Authors:  A Hidding; S van der Linden
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

8.  The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Donald L Patrick; Jordi Alonso; Paul W Stratford; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2010-02-19       Impact factor: 4.147

9.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

10.  Evaluation of quality of life using ASQoL questionnaire in patients with ankylosing spondylitis in a Chinese population.

Authors:  L K Zhao; Z T Liao; C H Li; T W Li; J Wu; Q Lin; F Huang; D T Yu; J R Gu
Journal:  Rheumatol Int       Date:  2006-11-14       Impact factor: 3.580

View more
  1 in total

1.  Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 study.

Authors:  Jinmei Su; Mengtao Li; Lan He; Dongbao Zhao; Weiguo Wan; Yi Liu; Jianhua Xu; Jian Xu; Huaxiang Liu; Lindi Jiang; Huaxiang Wu; Xiaoxia Zuo; Cibo Huang; Xiumei Liu; Fen Li; Zhiyi Zhang; Xiangyuan Liu; Lingli Dong; Tianwang Li; Haiying Chen; Jingyang Li; Dongyi He; Xin Lu; Anbin Huang; Yi Tao; Yanyan Wang; Zhuoli Zhang; Wei Wei; Xiaofeng Li; Xiaofeng Zeng
Journal:  Clin Rheumatol       Date:  2021-10-28       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.